Evidence map›Paper›PMID 42454847›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2026

Mortality pattern of cancer patients followed in Palliative Care: a retrospective analysis.

Filipe Veiga, Cristina Teixeira Pinto

Abstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Filipe VeigaUniversity of Porto, Faculty of Medicine - Porto, Portugal.ORCID http://orcid.org/0009-0000-4108-9951
Cristina Teixeira PintoUniversity of Porto, Faculty of Medicine - Porto, Portugal.ORCID http://orcid.org/0000-0003-4308-4526

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to identify the places of death of patients with solid cancer under follow-up by a Palliative Care team and to recognize factors that influence the place of death.

methodsRetrospective study of cancer patients whose deaths occurred between January 1, 2022, and January 1, 2024, followed up by a Palliative Care team in a Portuguese public hospital. Demographic and clinical data were reviewed through clinical file consultation and were analyzed by Statistical Package for the Social Sciences® v.29, considering a p<0.05 as statistically significant.

resultsThe sample included 413 cancer patients; 60.5% were male, and 72.9% were Eastern Cooperative Oncology Group 3-4. The median age was 75 years, and the median follow-up duration in Palliative Care was 40 days. Death in a hospital setting occurred in 64.4% of the patients. The most common types of cancer were gastrointestinal/hepato-bilio-pancreatic (41.6%) and lung cancers (18.6%). Death due to cancer progression was the main cause of death (88.4%). In a multivariate logistic regression, factors associated with higher odds of hospital death were age <75 years (OR 1.88, 95%CI 1.22-2.90) and follow-up duration in Palliative Care <30 days (OR 2.59, 95%CI 1.66-4.04). Death due to cancer progression was associated with lower odds of hospital death (OR 0.03, 95%CI 0.004-0.21).

conclusionDeath in a hospital setting was predominant in this sample, which is in line with outcomes from international studies. These findings highlight the need for early palliative care referral and advance care planning to support patients' preferences for place of death.

Indexed as

NeoplasmsPalliative CareAdultAgedAged, 80 and overCause of DeathFemaleHospital MortalityHumansMaleMiddle AgedPortugalRetrospective StudiesRisk Factors

Identifiers

PMID42454847
PMCPMC13361041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.